Early progressive encephalopathy in boys and MECP2 mutations

P. Kankirawatana, H. Leonard, C. Ellaway, J. Scurlock, A. Mansour, C. M. Makris, L. S. Dure IV, M. Friez, J. Lane, C. Kiraly-Borri, V. Fabian, M. Davis, J. Jackson, J. Christodoulou, W. E. Kaufmann, D. Ravine, A. K. Percy

    Research output: Contribution to journalArticle

    Abstract

    MECP2 mutations mainly occur in females with Rett syndrome. Mutations have been described in 11 boys with progressive encephalopathy: seven of nine with affected sisters and two de novo. The authors report four de novo occurrences: three pathogenic and one potentially pathogenic. Common features include failure to thrive, respiratory insufficiency, microcephaly, and abnormal motor control. MECP2 mutations should be assessed in boys with progressive encephalopathy and one or more of respiratory insufficiency, abnormal movements or tone, and intractable seizures.

    Original languageEnglish (US)
    Pages (from-to)164-166
    Number of pages3
    JournalNeurology
    Volume67
    Issue number1
    DOIs
    StatePublished - Jul 2006

    Fingerprint

    Brain Diseases
    Respiratory Insufficiency
    Mutation
    Rett Syndrome
    Failure to Thrive
    Microcephaly
    Dyskinesias
    Siblings
    Seizures

    ASJC Scopus subject areas

    • Neuroscience(all)

    Cite this

    Kankirawatana, P., Leonard, H., Ellaway, C., Scurlock, J., Mansour, A., Makris, C. M., ... Percy, A. K. (2006). Early progressive encephalopathy in boys and MECP2 mutations. Neurology, 67(1), 164-166. https://doi.org/10.1212/01.wnl.0000223318.28938.45

    Early progressive encephalopathy in boys and MECP2 mutations. / Kankirawatana, P.; Leonard, H.; Ellaway, C.; Scurlock, J.; Mansour, A.; Makris, C. M.; Dure IV, L. S.; Friez, M.; Lane, J.; Kiraly-Borri, C.; Fabian, V.; Davis, M.; Jackson, J.; Christodoulou, J.; Kaufmann, W. E.; Ravine, D.; Percy, A. K.

    In: Neurology, Vol. 67, No. 1, 07.2006, p. 164-166.

    Research output: Contribution to journalArticle

    Kankirawatana, P, Leonard, H, Ellaway, C, Scurlock, J, Mansour, A, Makris, CM, Dure IV, LS, Friez, M, Lane, J, Kiraly-Borri, C, Fabian, V, Davis, M, Jackson, J, Christodoulou, J, Kaufmann, WE, Ravine, D & Percy, AK 2006, 'Early progressive encephalopathy in boys and MECP2 mutations', Neurology, vol. 67, no. 1, pp. 164-166. https://doi.org/10.1212/01.wnl.0000223318.28938.45
    Kankirawatana P, Leonard H, Ellaway C, Scurlock J, Mansour A, Makris CM et al. Early progressive encephalopathy in boys and MECP2 mutations. Neurology. 2006 Jul;67(1):164-166. https://doi.org/10.1212/01.wnl.0000223318.28938.45
    Kankirawatana, P. ; Leonard, H. ; Ellaway, C. ; Scurlock, J. ; Mansour, A. ; Makris, C. M. ; Dure IV, L. S. ; Friez, M. ; Lane, J. ; Kiraly-Borri, C. ; Fabian, V. ; Davis, M. ; Jackson, J. ; Christodoulou, J. ; Kaufmann, W. E. ; Ravine, D. ; Percy, A. K. / Early progressive encephalopathy in boys and MECP2 mutations. In: Neurology. 2006 ; Vol. 67, No. 1. pp. 164-166.
    @article{de71180f8f034bd5b7ec1d67f122e0aa,
    title = "Early progressive encephalopathy in boys and MECP2 mutations",
    abstract = "MECP2 mutations mainly occur in females with Rett syndrome. Mutations have been described in 11 boys with progressive encephalopathy: seven of nine with affected sisters and two de novo. The authors report four de novo occurrences: three pathogenic and one potentially pathogenic. Common features include failure to thrive, respiratory insufficiency, microcephaly, and abnormal motor control. MECP2 mutations should be assessed in boys with progressive encephalopathy and one or more of respiratory insufficiency, abnormal movements or tone, and intractable seizures.",
    author = "P. Kankirawatana and H. Leonard and C. Ellaway and J. Scurlock and A. Mansour and Makris, {C. M.} and {Dure IV}, {L. S.} and M. Friez and J. Lane and C. Kiraly-Borri and V. Fabian and M. Davis and J. Jackson and J. Christodoulou and Kaufmann, {W. E.} and D. Ravine and Percy, {A. K.}",
    year = "2006",
    month = "7",
    doi = "10.1212/01.wnl.0000223318.28938.45",
    language = "English (US)",
    volume = "67",
    pages = "164--166",
    journal = "Neurology",
    issn = "0028-3878",
    publisher = "Lippincott Williams and Wilkins",
    number = "1",

    }

    TY - JOUR

    T1 - Early progressive encephalopathy in boys and MECP2 mutations

    AU - Kankirawatana, P.

    AU - Leonard, H.

    AU - Ellaway, C.

    AU - Scurlock, J.

    AU - Mansour, A.

    AU - Makris, C. M.

    AU - Dure IV, L. S.

    AU - Friez, M.

    AU - Lane, J.

    AU - Kiraly-Borri, C.

    AU - Fabian, V.

    AU - Davis, M.

    AU - Jackson, J.

    AU - Christodoulou, J.

    AU - Kaufmann, W. E.

    AU - Ravine, D.

    AU - Percy, A. K.

    PY - 2006/7

    Y1 - 2006/7

    N2 - MECP2 mutations mainly occur in females with Rett syndrome. Mutations have been described in 11 boys with progressive encephalopathy: seven of nine with affected sisters and two de novo. The authors report four de novo occurrences: three pathogenic and one potentially pathogenic. Common features include failure to thrive, respiratory insufficiency, microcephaly, and abnormal motor control. MECP2 mutations should be assessed in boys with progressive encephalopathy and one or more of respiratory insufficiency, abnormal movements or tone, and intractable seizures.

    AB - MECP2 mutations mainly occur in females with Rett syndrome. Mutations have been described in 11 boys with progressive encephalopathy: seven of nine with affected sisters and two de novo. The authors report four de novo occurrences: three pathogenic and one potentially pathogenic. Common features include failure to thrive, respiratory insufficiency, microcephaly, and abnormal motor control. MECP2 mutations should be assessed in boys with progressive encephalopathy and one or more of respiratory insufficiency, abnormal movements or tone, and intractable seizures.

    UR - http://www.scopus.com/inward/record.url?scp=33746861632&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=33746861632&partnerID=8YFLogxK

    U2 - 10.1212/01.wnl.0000223318.28938.45

    DO - 10.1212/01.wnl.0000223318.28938.45

    M3 - Article

    C2 - 16832102

    AN - SCOPUS:33746861632

    VL - 67

    SP - 164

    EP - 166

    JO - Neurology

    JF - Neurology

    SN - 0028-3878

    IS - 1

    ER -